SKLB 610

CAS No. 1125780-41-7

SKLB 610( SKLB610 | SKLB 610 | SKLB-610 )

Catalog No. M10442 CAS No. 1125780-41-7

SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 111 In Stock
25MG 210 In Stock
50MG 312 In Stock
100MG 462 In Stock
200MG 656 In Stock
500MG 972 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SKLB 610
  • Note
    Research use only, not for human use.
  • Brief Description
    SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.
  • Description
    SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SKLB610 | SKLB 610 | SKLB-610
  • Pathway
    Angiogenesis
  • Target
    FGFR
  • Recptor
    FGFR| PDGFR| VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1125780-41-7
  • Formula Weight
    415.37
  • Molecular Formula
    C21H16F3N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(NC)C1=NC=CC(OC2=CC=C(NC(C3=CC=CC(C(F)(F)F)=C3)=O)C=C2)=C1
  • Chemical Name
    N-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shah A, Mangaonkar A. Ann PharmacOthers. 2015 Jul 16.
molnova catalog
related products
  • Sucralfate

    Sucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.

  • LY344864

    LY344864, a specifc receptor agonist, is an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor.

  • hnps-PLA Inhibitor

    Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).